Renalytix Plc (RNLXY)
3.85
+0.15
(+4.05%)
USD |
OTCM |
Oct 23, 16:00
Renalytix Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 32.23M |
| October 22, 2026 | 30.92M |
| October 21, 2026 | 29.87M |
| October 20, 2026 | 29.87M |
| October 19, 2026 | 29.65M |
| October 16, 2026 | 29.17M |
| October 15, 2026 | 28.21M |
| October 14, 2026 | 29.17M |
| October 13, 2026 | 28.73M |
| October 12, 2026 | 29.96M |
| October 09, 2026 | 28.30M |
| October 08, 2026 | 31.79M |
| October 07, 2026 | 31.79M |
| October 06, 2026 | 31.09M |
| October 05, 2026 | 31.09M |
| October 02, 2026 | 33.54M |
| October 01, 2026 | 33.54M |
| September 30, 2026 | 31.71M |
| September 29, 2026 | 32.45M |
| September 28, 2026 | 33.54M |
| September 25, 2026 | 33.54M |
| September 24, 2026 | 33.54M |
| September 23, 2026 | 35.03M |
| September 22, 2026 | 33.54M |
| September 21, 2026 | 34.85M |
| Date | Value |
|---|---|
| September 18, 2026 | 34.85M |
| September 17, 2026 | 34.85M |
| September 16, 2026 | 35.03M |
| September 15, 2026 | 35.03M |
| September 14, 2026 | 34.15M |
| September 11, 2026 | 35.29M |
| September 10, 2026 | 32.67M |
| September 09, 2026 | 32.19M |
| September 08, 2026 | 32.19M |
| September 04, 2026 | 34.85M |
| September 03, 2026 | 37.78M |
| September 02, 2026 | 37.04M |
| September 01, 2026 | 32.44M |
| August 31, 2026 | 21.69M |
| August 28, 2026 | 21.83M |
| August 27, 2026 | 23.66M |
| August 26, 2026 | 22.96M |
| August 25, 2026 | 22.62M |
| August 24, 2026 | 22.27M |
| August 21, 2026 | 22.27M |
| August 20, 2026 | 22.75M |
| August 19, 2026 | 22.66M |
| August 18, 2026 | 23.27M |
| August 17, 2026 | 23.27M |
| August 14, 2026 | 22.83M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CompuMed, Inc. | 6.513M |
| Quest Diagnostics, Inc. | 32.49B |
| Labcorp Holdings, Inc. | 33.25B |
| Myriad Genetics, Inc. | 651.69M |
| OPKO Health, Inc. | 1.313B |